A BILL 
To amend the Controlled Substances Act to require physi-
cians and other prescribers of controlled substances to 
complete training on treating and managing patients 
with opioid and other substance use disorders (which 
shall also satisfy certain training required to receive a 
waiver for dispensing narcotic drugs for maintenance 
or detoxification treatment), and for other purposes. 
00:04 Nov 13, 2019
H4974
2 
•HR 4974 IH
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Medication Access and 
4
Training Expansion Act of 2019’’ or the ‘‘MATE Act of 
5
2019’’. 
6
SEC. 2. REQUIRING PRESCRIBERS OF CONTROLLED SUB-
7
STANCES 
TO 
COMPLETE 
TRAINING 
ON 
8
TREATING AND MANAGING PATIENTS WITH 
9
OPIOID AND OTHER SUBSTANCE USE DIS-
10
ORDERS. 
11
(a) IN GENERAL.—Section 303 of the Controlled 
12
Substances Act (21 U.S.C. 823) is amended by adding at 
13
the end the following: 
14
‘‘(l) REQUIRED TRAINING
FOR PRESCRIBERS
ON 
15
TREATING AND MANAGING PATIENTS WITH OPIOID AND 
16
OTHER SUBSTANCE USE DISORDERS.— 
17
‘‘(1) 
APPLICABILITY.—This 
subsection 
ap-
18
plies— 
19
‘‘(A) with respect to any practitioner who 
20
is licensed under State law to prescribe con-
21
trolled substances; and 
22
‘‘(B) beginning with the first registration 
23
or renewal of registration by the practitioner 
24
under this section occurring 90 or more days 
25
00:04 Nov 13, 2019
H4974
3 
•HR 4974 IH
after the date of enactment of the Medication 
1
Access and Training Expansion Act of 2019. 
2
‘‘(2) TRAINING REQUIRED.—As a condition on 
3
registration under this section to dispense controlled 
4
substances in schedule II, III, IV, or V, the Attorney 
5
General shall require any practitioner described in 
6
paragraph (1)(A) to meet the following: 
7
‘‘(A) If the practitioner is a physician, the 
8
practitioner must meet one or more of the fol-
9
lowing conditions: 
10
‘‘(i) The physician holds a board cer-
11
tification in addiction psychiatry or addic-
12
tion medicine from the American Board of 
13
Medical Specialties. 
14
‘‘(ii) The physician holds an addiction 
15
certification or board certification from the 
16
American Society of Addiction Medicine or 
17
the American Board of Addiction Medicine. 
18
‘‘(iii) The physician holds a board cer-
19
tification in addiction medicine from the 
20
American Osteopathic Association. 
21
‘‘(iv) The physician has, with respect 
22
to the treatment and management of pa-
23
tients with opioid and other substance use 
24
disorders, completed not less than 8 hours 
25
00:04 Nov 13, 2019
H4974
4 
•HR 4974 IH
of training (through classroom situations, 
1
seminars at professional society meetings, 
2
electronic communications, or otherwise) 
3
that is provided by the American Society of 
4
Addiction Medicine, the American Acad-
5
emy of Addiction Psychiatry, the American 
6
Medical Association, the American Osteo-
7
pathic Association, the American Psy-
8
chiatric Association, or any other organiza-
9
tion that the Secretary determines is ap-
10
propriate for purposes of this clause. Such 
11
training shall include— 
12
‘‘(I) opioid maintenance and de-
13
toxification; 
14
‘‘(II) appropriate clinical use of 
15
all drugs approved by the Food and 
16
Drug Administration for the treat-
17
ment of a substance use disorder; 
18
‘‘(III) initial and periodic patient 
19
assessments (including substance use 
20
monitoring); 
21
‘‘(IV) individualized treatment 
22
planning, overdose reversal, and re-
23
lapse prevention; 
24
00:04 Nov 13, 2019
H4974
5 
•HR 4974 IH
‘‘(V) counseling and recovery 
1
support services; 
2
‘‘(VI) staffing roles and consider-
3
ations; 
4
‘‘(VII) diversion control; and 
5
‘‘(VIII) other best practices, such 
6
as prevention of addiction, as identi-
7
fied by the Secretary, after consulta-
8
tion with practitioners from a variety 
9
of medical specialties and who prac-
10
tice in different settings in which con-
11
trolled substances are prescribed. 
12
‘‘(v) The physician has participated as 
13
an investigator in one or more clinical 
14
trials leading to the approval of a narcotic 
15
drug in schedule III, IV, or V for mainte-
16
nance or detoxification treatment, as dem-
17
onstrated by a statement submitted to the 
18
Secretary by the sponsor of such approved 
19
drug. 
20
‘‘(vi) The physician has such other 
21
training or experience as the State medical 
22
licensing board of the State where the phy-
23
sician will provide maintenance or detoxi-
24
fication 
treatment 
considers 
to 
dem-
25
00:04 Nov 13, 2019
H4974
6 
•HR 4974 IH
onstrate the ability of the physician to 
1
treat and manage patients with opioid and 
2
other substance use disorders. 
3
‘‘(vii) The physician has such other 
4
training or experience as the Secretary 
5
considers to demonstrate the ability of the 
6
physician to treat and manage patients 
7
with opioid and other substance use dis-
8
orders. Any criteria of the Secretary under 
9
this clause shall be established by regula-
10
tion. Any such criteria are effective only 
11
for 3 years after the date on which the cri-
12
teria are promulgated, but may be ex-
13
tended for such additional discrete 3-year 
14
periods as the Secretary considers appro-
15
priate for purposes of this clause. Such an 
16
extension of criteria may only be effec-
17
tuated through a statement published in 
18
the Federal Register by the Secretary dur-
19
ing the 30-day period preceding the end of 
20
the 3-year period involved. 
21
‘‘(viii) The physician graduated in 
22
good standing from an accredited school of 
23
allopathic medicine or osteopathic medicine 
24
in the United States during the 5-year pe-
25
00:04 Nov 13, 2019
H4974
7 
•HR 4974 IH
riod immediately preceding the date on 
1
which the physician first registers or re-
2
news under this section and has success-
3
fully completed a comprehensive allopathic 
4
or osteopathic medicine curriculum or ac-
5
credited medical residency that— 
6
‘‘(I) included not less than 8 
7
hours of training on treating and 
8
managing patients with opioid and 
9
other substance use disorders; and 
10
‘‘(II) included, at a minimum— 
11
‘‘(aa) the training described 
12
in subclauses (I) through (VIII) 
13
of clause (iv); and 
14
‘‘(bb) training with respect 
15
to any other best practice the 
16
Secretary determines should be 
17
included in the curriculum, which 
18
may include training on pain 
19
management, including assess-
20
ment and appropriate use of 
21
opioid 
and 
non-opioid 
alter-
22
natives. 
23
00:04 Nov 13, 2019
H4974
8 
•HR 4974 IH
‘‘(B) If the practitioner is not a physician, 
1
the practitioner must meet one or more of the 
2
following conditions: 
3
‘‘(i) Completed not fewer than 24 
4
hours of initial training addressing each of 
5
the topics listed in subparagraph (A)(iv) 
6
(through classroom situations, seminars at 
7
professional society meetings, electronic 
8
communications, or otherwise) provided by 
9
the American Society of Addiction Medi-
10
cine, the American Academy of Addiction 
11
Psychiatry, the American Medical Associa-
12
tion, the American Osteopathic Associa-
13
tion, the American Nurses Credentialing 
14
Center, the American Psychiatric Associa-
15
tion, the American Association of Nurse 
16
Practitioners, the American Academy of 
17
Physician Assistants, or any other organi-
18
zation that the Secretary determines is ap-
19
propriate for purposes of this clause. 
20
‘‘(ii) Has such other training or expe-
21
rience as the Secretary determines will 
22
demonstrate the ability of the practitioner 
23
to treat and manage patients with opioid 
24
and other substance use disorders. 
25
00:04 Nov 13, 2019
H4974
9 
•HR 4974 IH
‘‘(iii) Graduated in good standing 
1
from an accredited physician assistant 
2
school or school of advanced practice nurs-
3
ing in the United States during the 5-year 
4
period immediately preceding the date on 
5
which the practitioner first registers or re-
6
news under this section and has success-
7
fully completed a comprehensive physician 
8
assistant or advanced practice nursing cur-
9
riculum that includes not less than 24 
10
hours of training on treating and man-
11
aging patients with opioid and other sub-
12
stance use disorders and, at a minimum— 
13
‘‘(I) the training described in 
14
subclauses (I) through (VIII) of sub-
15
paragraph (A)(iv); and 
16
‘‘(II) training with respect to any 
17
other best practice the Secretary de-
18
termines should be included in the 
19
curriculum, which may include train-
20
ing on pain management, including 
21
assessment and appropriate use of 
22
opioid and non-opioid alternatives. 
23
‘‘(3) RECIPROCAL TREATMENT.— 
24
00:04 Nov 13, 2019
H4974
10 
•HR 4974 IH
‘‘(A) PHYSICIANS.—A physician who meets 
1
one or more of the conditions listed in para-
2
graph (2)(A) is deemed to meet one or more of 
3
the conditions listed in subsection (g)(2)(G)(ii), 
4
and a physician who meets one or more of the 
5
conditions listed in subsection (g)(2)(G)(ii) is 
6
deemed to meet one or more of the conditions 
7
listed in paragraph (2)(A). 
8
‘‘(B) OTHER
PRACTITIONERS.—A practi-
9
tioner who is not a physician, and who meets 
10
one or more of the conditions listed in para-
11
graph (2)(B), is deemed to meet one or more 
12
of 
the 
conditions 
listed 
in 
subsection 
13
(g)(2)(G)(iv)(II), and a practitioner who is not 
14
a physician, and who meets one or more of the 
15
conditions listed in subsection (g)(2)(G)(iv)(II), 
16
is deemed to meet one or more of the conditions 
17
listed in paragraph (2)(B).’’. 
18
(b) TRAINING REQUIRED.— 
19
(1) 
PHYSICIANS.—Section 
20
303(g)(2)(G)(ii)(IV)(hh) of the Controlled Sub-
21
stances Act (21 U.S.C. 823(g)(2)(G)(ii)(IV)) is 
22
amended by inserting ‘‘such as prevention of addic-
23
tion,’’ after ‘‘other best practices,’’. 
24
00:04 Nov 13, 2019
H4974
11 
•HR 4974 IH
(2) 
OTHER
PRACTITIONERS.—Section 
1
303(g)(2)(G)(iv)(II) of the Controlled Substances 
2
Act (21 U.S.C. 823(g)(2)(G)(iv)(II)) is amended— 
3
(A) in item (aa), by striking ‘‘or’’ at the 
4
end; 
5
(B) in item (bb), by striking the period at 
6
the end and inserting ‘‘; or’’; and 
7
(C) by adding at the end the following new 
8
item: 
9
‘‘(cc) graduated in good standing from an 
10
accredited physician assistant school or school 
11
of advanced practice nursing in the United 
12
States during the 5-year period immediately 
13
preceding the date on which the practitioner 
14
submits to the Secretary a written notification 
15
under subparagraph (B) and has successfully 
16
completed a comprehensive physician assistant 
17
or advanced practice nursing curriculum that 
18
includes not less than 24 hours of training on 
19
treating and managing opioid-dependent pa-
20
tients and, at a minimum— 
21
‘‘(AA) the training described in items 
22
(aa) through (hh) of clause (ii)(IV); and 
23
‘‘(BB) training with respect to any 
24
other best practice the Secretary deter-
25
00:04 Nov 13, 2019
H4974
12 
•HR 4974 IH
mines should be included in the cur-
1
riculum, which may include training on 
2
pain management, including assessment 
3
and appropriate use of opioid and non- 
4
opioid alternatives.’’. 
5
(3) 
TECHNICAL
CORRECTION.—Section 
6
303(g)(2)(G)(iv)(II)(bb) of the Controlled Sub-
7
stances Act (21 U.S.C. 823(g)(2)(G)(iv)(II)(bb)) is 
8
amended by striking ‘‘has’’ before ‘‘such other train-
9
ing’’. 
10
Æ 
00:04 Nov 13, 2019
H4974
